Download PDF
Am J Perinatol 2007; 24(2): 127-135
DOI: 10.1055/s-2007-970078
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Fungal Colonization in the Neonatal Intensive Care Unit: Risk Factors, Drug Susceptibility, and Association with Invasive Fungal Infections

Evangelia Farmaki1 , Joanna Evdoridou2 , Theodora Pouliou2 , Evangelia Bibashi3 , Paraskevi Panagopoulou1 , Joanna Filioti1 , Alexis Benos4 , Danai Sofianou3 , George Kremenopoulos2 , Emmanuel Roilides1
  • 13rd Department of Pediatrics, Aristotle University, Thessaloniki, Greece
  • 21st Department of Neonatology, Aristotle University, Thessaloniki, Greece
  • 3Microbiology Department, Hippokration Hospital, Thessaloniki, Greece
  • 4Laboratory of Hygiene, Medical School, Aristotle University, University Campus, Thessaloniki, Greece
Further Information

Publication History

Publication Date:
15 February 2007 (online)

    Permissions and Reprints

ABSTRACT

A prospective study was conducted to determine risk factors for fungal colonization, drug susceptibility, and association with invasive fungal infections (IFIs) in a neonatal unit. On admission and weekly thereafter, surveillance fungal cultures were taken from mouth, rectum, and trachea of neonates with expected stays of > 1 week. Fungal colonization was detected in 72 (12.1%) of 593 neonates during 12 months. Candida albicans was isolated from 42% of colonized neonates. Although early colonization (age 1.3 ± 0.2 days) was found in 2.5% of the neonates, late colonization (age 17.6 ± 1.4 days) was noted in 14.2% of neonates hospitalized for > 5 days. Neonates born vaginally were at higher risk for early colonization than those delivered after cesarean section (p = 0.01). By multivariate logistic regression, very low birthweight was the only independent risk factor for late colonization. Ten IFIs (nine candidemias) were diagnosed, yielding a rate of 1.1%. These episodes occurred in 6.9% of colonized neonates, compared with 0.76% of noncolonized neonates (p = 0.002). C. albicans was susceptible to azoles, but some non-albicans Candida spp. exhibited decreased susceptibility to these drugs.

KEYWORDS

Colonization - Candida spp. - neonate - drug susceptibility

REFERENCES

  • 1 Kossoff E H, Buescher E S, Karlowicz M G. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases.  Pediatr Infect Dis J. 1998;  17 504-508
    CrossrefPubMedGoogle Scholar
  • 2 Roilides E, Farmaki E, Evdoridou J et al.. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.  Eur J Clin Microbiol Infect Dis. 2004;  23 745-750
    CrossrefPubMedGoogle Scholar
  • 3 Lopez Sastre J B, Coto Collado G D, Colomer B F et al.. Neonatal invasive candidiasis: A prospective multicenter study of 118 cases.  Am J Perinatol. 2003;  20 153-163
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Kaufman D. Fungal infection in the very low birthweight infant.  Curr Opin Infect Dis. 2004;  17 253-259
    CrossrefPubMedGoogle Scholar
  • 5 El-Masry F A, Neal T J, Subhedar N V. Risk factors for invasive fungal infection in neonates.  Acta Paediatr. 2002;  91 198-202
    CrossrefPubMedGoogle Scholar
  • 6 Roilides E, Kadiltsoglou I, Zahides D et al.. Invasive candidosis in pediatric patients.  Clin Microbiol Infect. 1997;  3 192-197
    PubMedGoogle Scholar
  • 7 Rangel-Frausto M S, Wiblin T, Blumberg H M et al.. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.  Clin Infect Dis. 1999;  29 253-258
    PubMedGoogle Scholar
  • 8 Kaufman D, Boyle R, Hazen K C et al.. Fluconazole prophylaxis against fungal colonization and infection in preterm infants.  N Engl J Med. 2001;  345 1660-1666
    CrossrefPubMedGoogle Scholar
  • 9 Kicklighter S D, Springer S C, Cox T et al.. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant.  Pediatrics. 2001;  107 293-298
    CrossrefPubMedGoogle Scholar
  • 10 Saiman L, Ludington E, Dawson J D et al.. Risk factors for Candida species colonization of neonatal intensive care unit patients.  Pediatr Infect Dis J. 2001;  20 1119-1124
    CrossrefPubMedGoogle Scholar
  • 11 Huang Y C, Li C C, Lin T Y et al.. Association of fungal colonization and invasive disease in very low birth weight infants.  Pediatr Infect Dis J. 1998;  17 819-822
    CrossrefPubMedGoogle Scholar
  • 12 Waggoner-Fountain L A, Whit Walker M, Hollis R J et al.. Vertical and horizontal transmission of unique Candida species to premature newborns.  Clin Infect Dis. 1996;  22 803-808
    PubMedGoogle Scholar
  • 13 Reef S E, Lasker B A, Butcher D S et al.. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study.  J Clin Microbiol. 1998;  36 1255-1259
    PubMedGoogle Scholar
  • 14 Lupetti A, Tavanti A, Davini P et al.. Horizontal transmission of Candida parapsilosis candidemia in a Neonatal Intensive Care Unit.  J Clin Microbiol. 2002;  40 2363-2369
    CrossrefPubMedGoogle Scholar
  • 15 Saiman L, Ludington E, Pfaller M et al.. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.  Pediatr Infect Dis J. 2000;  19 319-324
    CrossrefPubMedGoogle Scholar
  • 16 National Committee for Clinical Laboratory Standards .Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. Wayne, PA; National Committee for Clinical Laboratory Standards 2002
    Google Scholar
  • 17 Rex J H, Pfaller M A, Galgiani J N et al.. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.  Clin Infect Dis. 1997;  24 235-247
    CrossrefPubMedGoogle Scholar
  • 18 Roilides E, Farmaki E, Evdoridou J et al.. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.  J Clin Microbiol. 2003;  41 735-741
    CrossrefPubMedGoogle Scholar
  • 19 Huang Y, Lin T, Peng H et al.. Outbreak of Candida albicans fungaemia in a neonatal intensive care unit.  Scand J Infect Dis. 1998;  30 137-142
    CrossrefPubMedGoogle Scholar
  • 20 Baley J E, Kliegman R M, Boxerbaum B et al.. Fungal colonization in the very low birth weight infant.  Pediatrics. 1986;  78 225-232
    PubMedGoogle Scholar
  • 21 Levy I, Rubin L G, Vasistha S et al.. Emergence of Candida parapsilosis as the predominant species causing candidaemia in children.  Clin Infect Dis. 1998;  26 1086-1088
    PubMedGoogle Scholar
  • 22 Sarvikivi E, Lyytikainen O, Soll D R et al.. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a Neonatal Intensive Care Unit.  J Clin Microbiol. 2005;  43 2729-2735
    CrossrefPubMedGoogle Scholar
  • 23 Huang Y C, Lin R I, Chou Y H et al.. Candidaemia in special care nurseries: Comparison of albicans and parapsilosis infection.  J Infect. 2000;  40 171-175
    CrossrefPubMedGoogle Scholar
  • 24 Faix R G, Finkel D J, Andersen R D et al.. Genotypic analysis of a cluster of systemic Candida albicans infections in a neonatal intensive care unit.  Pediatr Infect Dis J. 1995;  14 1063-1068
    PubMedGoogle Scholar
  • 25 Reagan D R, Pfaller M A, Hollis R J et al.. Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit.  Diagn Microbiol Infect Dis. 1995;  21 191-194
    CrossrefPubMedGoogle Scholar
  • 26 Welbel S F, McNeil M M, Kuykendall R J et al.. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak.  Pediatr Infect Dis J. 1996;  15 998-1002
    CrossrefPubMedGoogle Scholar
  • 27 Huang Y C, Lin T Y, Leu H S et al.. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis.  Infection. 1999;  27 97-102
    PubMedGoogle Scholar
  • 28 da Silva C L, dos Santos R M, Colombo A L. Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit.  Braz J Infect Dis. 2001;  5 32-36
    PubMedGoogle Scholar
  • 29 Walsh T J, Merz W G. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. .  Am J Clin Pathol. 1986;  85 498-502
    PubMedGoogle Scholar
  • 30 Leung A Y, Chim C S, Ho P L et al.. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors.  J Hosp Infect. 2002;  50 316-319
    CrossrefPubMedGoogle Scholar
  • 31 Flynn P M, Marina N M, Rivera G K et al.. Candida tropicalis infections in children with leukemia.  Leuk Lymphoma. 1993;  10 369-376
    PubMedGoogle Scholar
  • 32 Sobel J D, Wiesenfeld H C, Martens M et al.. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.  N Engl J Med. 2004;  351 876-883
    CrossrefPubMedGoogle Scholar
  • 33 Girmenia C, Martino P, De Bernardis F et al.. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains.  Clin Infect Dis. 1996;  23 506-514
    PubMedGoogle Scholar
  • 34 el-Mohandes A E, Johnson-Robbins L, Keiser J F et al.. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease.  Pediatr Infect Dis J. 1994;  13 520-524
    PubMedGoogle Scholar
  • 35 Verma A, Wade J J, Cheeseman P et al.. Risk factors for fungal infection in paediatric liver transplant recipients.  Pediatr Transplant. 2005;  9 220-225
    CrossrefPubMedGoogle Scholar
  • 36 Rowen J L, Tate J M, Nordoff N et al.. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility.  J Clin Microbiol. 1999;  37 3735-3737
    PubMedGoogle Scholar

Emmanuel RoilidesM.D. 

3rd Department of Pediatrics, Hippokration Hospital

Konstantinoupoleos 49, GR-546 42 Thessaloniki, Greece

      >